1. Home
  2. ONC vs TYL Comparison

ONC vs TYL Comparison

Compare ONC & TYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • TYL
  • Stock Information
  • Founded
  • ONC 2010
  • TYL 1966
  • Country
  • ONC Switzerland
  • TYL United States
  • Employees
  • ONC N/A
  • TYL N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • TYL Computer Software: Prepackaged Software
  • Sector
  • ONC Health Care
  • TYL Technology
  • Exchange
  • ONC Nasdaq
  • TYL Nasdaq
  • Market Cap
  • ONC 26.9B
  • TYL 24.7B
  • IPO Year
  • ONC N/A
  • TYL N/A
  • Fundamental
  • Price
  • ONC $245.58
  • TYL $577.02
  • Analyst Decision
  • ONC Strong Buy
  • TYL Buy
  • Analyst Count
  • ONC 7
  • TYL 11
  • Target Price
  • ONC $326.43
  • TYL $687.82
  • AVG Volume (30 Days)
  • ONC 368.4K
  • TYL 243.1K
  • Earning Date
  • ONC 05-07-2025
  • TYL 07-23-2025
  • Dividend Yield
  • ONC N/A
  • TYL N/A
  • EPS Growth
  • ONC N/A
  • TYL 50.34
  • EPS
  • ONC N/A
  • TYL 6.63
  • Revenue
  • ONC $4,180,740,829.00
  • TYL $2,190,609,000.00
  • Revenue This Year
  • ONC $32.78
  • TYL $10.16
  • Revenue Next Year
  • ONC $19.07
  • TYL $9.68
  • P/E Ratio
  • ONC N/A
  • TYL $87.05
  • Revenue Growth
  • ONC 52.09
  • TYL 9.96
  • 52 Week Low
  • ONC $141.31
  • TYL $458.50
  • 52 Week High
  • ONC $287.88
  • TYL $661.31
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • TYL 57.59
  • Support Level
  • ONC N/A
  • TYL $566.47
  • Resistance Level
  • ONC N/A
  • TYL $580.27
  • Average True Range (ATR)
  • ONC 0.00
  • TYL 10.53
  • MACD
  • ONC 0.00
  • TYL 1.22
  • Stochastic Oscillator
  • ONC 0.00
  • TYL 83.65

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About TYL Tyler Technologies Inc.

Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.

Share on Social Networks: